Barcode 2501220013 Test Request id 51901

Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46

Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:35
Sample Type Plain Serum, Serum Client Code

WELLCARE 1.3 NEW

BLOOD GLUCOSE LEVEL ( FASTING ) 94.6 mg/dl 60 - 110
Interpretation :
Fasting Blood Sugar more than 126 mg/dl on more than one occasion can indicate Diabetes Mellitus.
COMMENTS
Interpretation Elevated glucose levels (hyperglycemia) are most often encountered clinically in the setting of diabetes mellitus, but
they may also occur with pancreatic neoplasms, hyperthyroidism, and adrenocortical dysfunction. Decreased glucose levels
(hypoglycemia) may result from endogenous or exogenous insulin excess, prolonged starvation, or liver disease.
Note :
The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease, it has
to be correlated with clinical data for interpretation.

**** End Of Report ****

Page 1
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:36
Sample Type EDTA Blood Client Code

COMPLETE BLOOD COUNT (CBC)

Test Name Result Unit Normal Value

HAEMOGLOBIN (Hb) 15.3 gm/dl 13.5 - 18.0

TOTAL LEUCOCYTE COUNT (TLC) 8,380 /cumm 4000 - 11000

DIFFERENTIAL LEUCOCYTE COUNT (DLC)

NEUTROPHIL 73 % 40 - 75
LYMPHOCYTE 23 % 20 - 45
EOSINOPHIL 02 % 01 - 06
MONOCYTE 02 % 02 - 10
BASOPHIL 00 % 0-0

RBC Indices

P.C.V / HAEMATOCRIT 42.8 % 40 - 54

R B C COUNT 4.47 Millions/cmm 4.5 - 5.5
MCV 95.75 fl. 80 - 100
MCH 34.23 Picogram 27.0 - 31.0
MCHC 35.7 gm/dl 33 - 37
RDW-CV 11.9 % 11.5 - 14.5
RDW-SD 46.3 fL 36.0 - 56.0

Platelet Indices

PLATELET COUNT 1.90 Lakh/cmm 1.50 - 4.00

MPV 11.2 fL 7.4 - 10.4

Page 2
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:36
Sample Type EDTA Blood Client Code

PDW-CV 15.1 % 9 - 17
PCT 0.214 % 0.10 - 0.282
ESR (WESTEGREN`s METHOD) 12 mm/Ist hr. 0 - 15
Absolute NEUTROPHIL 6.117 10^3/uL 0 - 15
Absolute LYMPHOCYTE 1.927 10^3/uL 1.0 - 3.0
Absolute EOSINOPHIL 0.168 10^3/uL 0.02 - 0.5
Absolute MONOCYTE 0.168 10^3/uL 0.2 - 1
Absolute BASOPHIL 0 10^3/uL 0.0 - 0.0
Neutrophil - Lymphocyte Ratio (NLR) 3.174 %
Calculated

Lymphocyte - Monocyte Ratio (LMR) 11.5 %

Calculated

Platelet - Lymphocyte Ratio (PLR) 0.083 %

Calculated

P-LCR 37.6 % 16 - 41
P-LCC 72 % 44 - 140
A complete blood count (CBC) is a blood test used to evaluate your overall health and detect a wide range of disorders, including
anemia, infection and leukemia. A complete blood count test measures several components and features of your blood, including:
Red blood cells, which carry oxygen

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 3 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:37
Sample Type Client Code

URINE ROUTINE EXAMINATION

Physical Examination
Quantity 25 ml -

Colour Pale Yellow Pale yellow/Yellow

Specific Gravity 1.015 1.005-1.025

pH 6.5 5.0 - 8.0

Deposit Absent Absent

Chemical Examination

Protein Absent Absent

Sugar Absent Absent

Ketones Absent Absent

Bile Salt Absent Absent

Bile Pigment Absent Absent

Urobilinogen Normal Normal

Microscopic Examination (/hpf)

Pus Cell 2-4 Upto 5

Epithelial Cells 2-4 Upto 5

Red Blood Cells Absent Absent

Casts Absent Absent

Crystals Absent Absent

Page 4
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:37
Sample Type Client Code

Amorphous Deposit Absent Absent

Yeast Cells Absent Absent

Bacteria Absent Absent

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 5 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:38
Sample Type Plain Serum, Serum Client Code

LIVER FUNCTION TEST (LFT)

Test Name Result Unit Normal Value

BILIRUBIN TOTAL 0.29 mg/dl 0.1 - 1.20

CONJUGATED (D. Bilirubin) 0.19 mg/dl 0.1 - 0.40
UNCONJUGATED (I.D.Bilirubin) 0.1 mg/dl 0.00 - 0.70
TOTAL PROTEIN 6.83 gm/dl 6.6 - 8.3
ALBUMIN 4.03 gm/dl 3.4 - 4.8
GLOBULIN 2.8 gm/dl 2.3 - 3.5
A/G RATIO 1.439
SGOT 28.7 IU/L 0 - 40
SGPT 41.4 IU/L 0.0 - 41.0
SGOT / SGPT Ratio 0.693 Ratio
ALKALINE PHOSPHATASE 110 U/L 40.0 - 130.0
IFCC Method
COMMENTS
These are group of tests that can be used to detect the presence of liver disease, distinguish among different types of liver disorders,
gauge the extent of known liver damage, and monitor the response to treatment. Most liver diseases cause only mild symptoms
initially, but these diseases must be detected early. Some tests are associated with functionality (e.g., albumin), some with cellular
integrity (e.g., transaminase), and some with conditions linked to the biliary tract (gamma-glutamyl transferase and alkaline
phosphatase). Conditions with elevated levels of ALT and AST include hepatitis A,B ,C ,paracetamol toxicity etc.Several biochemical
tests are useful in the evaluation and management of patients with hepatic dysfunction. Some or all of these measurements are also
carried out (usually about twice a year for routine cases) on those individuals taking certain medications, such as anticonvulsants, to
ensure that the medications are not adversely impacting the person's liver.
Note : The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease,
it has to be correlated with clinical data for interpretation.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 6 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:39
Sample Type Plain Serum, Serum Client Code

KIDNEY FUNCTION TEST (KFT)

Test Name Result Unit Normal Value

BLOOD UREA 28.1 mg /dl 15.0 - 45.0

SERUM CREATININE 0.84 mg% 0.7 - 1.4
SERUM URIC ACID 7.8 mg% 3.4 - 7.0
BLOOD UREA NITROGEN (BUN) 13.131 mg% 6.0 - 20.0
UREA / CREATININE Ratio 33.452 Ratio
BUN / CREATININE Ratio 15.632 Ratio

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 7 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:39
Sample Type Plain Serum, Serum Client Code

BIOCHEMISTRY
Test Name Result Unit Normal Value

SERUM ELECTROLYTE PROFILE

SODIUM 144.18 mmol/L 135.0 - 150.0

POTASSIUM 3.92 mmol/L 3.5 - 5.5
CHLORIDE 102.00 mmol/L 98.0 - 109.0

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 8 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:39
Sample Type Plain Serum, Serum Client Code

LIPID PROFILE

Test Name Result Unit Normal Value

TRIGLYCERIDES 114.2 mg/dL 40.0 - 165.0

TOTAL CHOLESTEROL 169 mg/dL 123.0 - 199.0
H D L CHOLESTEROL DIRECT 46.9 mg/dL 40.0 - 79.4
VLDL 22.84 mg/dL 4.7 - 22.1
L D L CHOLESTEROL DIRECT 99.26 mg/dL 63.0 - 129.0
TOTAL CHOLESTEROL/HDL RATIO 3.603 0.0 - 4.97
LDL / HDL CHOLESTEROL RATIO 2.116 0.00 - 3.55
NON-HDL CHOLESTEROL 121.1 mg/dl 0-0
Clinical Notes:
Lipid profile is initial screening tool for abnormalities in lipids. The results of this test can identify certain genetic diseases & can
determine approximate risks for cardiovascular disease, certain forms of pancreatitis. Hypertriglyceridemia is indicative of insulin
resistance when present with low HDL & elevated LDL.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 9 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:40
Sample Type Plain Serum, Serum Client Code

CALCIUM

Test Name Result Unit Normal Value

CALCIUM 8.8 mg/dl 8.5 - 10.5

COMMENTS
CLINICAL NOTES
A blood calcium test is ordered to screen for, diagnose, and monitor a range of conditions relating to the bones, heart, nerves,
kidneys, and teeth. The test may also be ordered if a person has symptoms of a parathyroid disorder, malabsorption, or an overactive
thyroid. To help diagnose the underlying problem, additional tests are often done to measure ionized calcium, urine calcium,
phosphorus, magnesium, vitamin D, parathyroid hormone (PTH) and PTH-related peptide (PTHrP). PTH and vitamin D are
responsible for maintaining calcium concentrations in the blood within a narrow range of values. Measuring urine calcium can help
determine whether the kidneys are excreting the proper amount of calcium, Serum calcium is decreased (hypocalcemia) in following
conditions-Hypoparathyroidism,Pseudohypoparathyroidism -Vitamin D deficiency (either from intake deficiency or decreased
conversion/activation) or resistance (osteomalacia and rickets) -Chronic renal diseases (eg, renal acidosis, Fanconi
syndrome),Chronic liver disease and biliary obstructive diseases -Magnesium deficiency (PTH glandular release is
magnesium-dependent),Hyperphosphatemia,Hypoalbuminemia -Overexpression of fibroblast growth factor 23 (oncogenic
osteomalacia) -Severe calcium dietary deficiency,

Note : The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a
disease, it has to be correlated with clinical data for interpretation.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 10 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:41
Sample Type EDTA Blood, Serum Client Code

SERUM VITAMIN B12 213.7 pg/ml 220 - 914

Clinical significance :
• Vitamin B 12 deficiency frequently causes macrocytic anemia, glossitis, peripheral neuropathy, weakness, hyperreflexia, ataxia,
loss of proprioception, poor coordination and affective behavioral changes.
• Many patients have the neurologic defects without macrocytic anemia. Serum methylmalonic acid (MMA) and homocysteine levels
are also elevated in Vit B 12 deficiency states.
• Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat,
eggs and milk.
• It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias.
• For diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination
and other findings.

Please correlate with clinical conditions.

Limitations:
• The evaluation of macrocytic anemia requires measurement of both vitamin B12 and Folate levels: ideally they should be
measured simultaneously.
• Specimen collection soon after blood transfusion can falsely increase Vit B12 levels.
• Patient taking Vit B12 supplementation may have misleading results.
• A normal serum concentration of B12 does not rule out tissue deficiency of Vit B12. The most sensitive test at the cellular level is
the assay for MMA.
• If Clinical symptoms suggest deficiency, measurement of MMA and Homocysteine should be considered, even if serum B12
concentrations are normal.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 11 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:43
Sample Type Serum Client Code

VITAMIN D 25 HYDROXY 9.21 ng/mL 20 - 100

CLIA Deficiency < 20
Insufficiency : 20 - 30
Sufficiency : 30 - 100
Toxicity > 150
COMMENTS
CLINICAL NOTES
Vitamin D is essential for strong bones, because it helps the body use calcium from the diet. Traditionally, vitamin D deficiency has
been associated with rickets, a disease in which the bone tissue doesn't properly mineralize, leading to soft bones and skeletal
deformities. But increasingly, research is revealing the importance of vitamin D in protecting against a host of health problems.

Symptoms and Health risks of vitamin D deficiency Symptoms of bone pain and muscle weakness can mean you have a vitamin D
deficiency. However, for many people, the symptoms are subtle. Yet, even without symptoms, too little vitamin D can pose health
risks. Low blood levels of the vitamin have been associated with Increased risk of cardiovascular disease, Cognitive impairment in
older adults, Severe asthma in children & Cancer. Research suggests that vitamin D could play a role in the prevention and
treatment of a number of different conditions, including type1 and type 2 diabetes, hypertension, glucose intolerance, and multiple
sclerosis.

Causes of vitamin D deficiency

-Peoplle following a strict vegan diet.
-Exposure to sunlight is limited,
-Vitamin D malabsorption
- like Crohn's disease, cystic fibrosis, and celiac disease,
-Dietary deficiency -Severe Hepatocellular disease
-Drugs like Anticonvulsants
-Nephrotic syndrome Increased levels
-Vitamin D intoxication Reference ranges vary between laboratories.

Note : The result obtained relate only to the sample given/ received & tested. A single test result is not always indicative of a disease,
it has to be correlated with clinical data for interpretation.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 12 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:44
Sample Type Serum Client Code

THYROID PROFILE

Test Name Result Unit Normal Value

T3 1.43 ng/ml 0.70 - 1.80

Method : PMP - CLIA

T4 9.25 ug/dl 4.6 - 10.50

Method : PMP - CLIA

TSH 1.912 uIU/ml 0.35 - 5.50

Method : PMP - CLIA

Reference range for < 18 years

TEST 1- 3 D 4 - 30 D 31 - 6 0 D 61 D - 12 M 1- 5 Y 6 - 10 Y 11 - 1 4 Y 15 - 1 8 Y
TSH 0.1-9.2 0.2-8.5 0.2-7.8 0.30-5.9 0.4-4.8 0.5-4.7 0.5-4.6 0.6-4.5
T3 41.7-272.1 48.2-272.1 54.7-272.1 76.8-272.1 89.2-246.7 87.2-218.1 86.6-199.8 85.3-188.8
T4 4.9-15.8 5-15.3 5.2-14.8 5.7-13.3 5.7-11.7 5.4-10.7 5.2-10 5.1-9.6
FT3 1.5-5.3 1.6-5.2 1.6-5.1 1.8-4.8 2-4.5 2.1-4.4 2.3-4.4 2.3-4.3
FT4 0.84-2.08 0.85-1.98 0.85-1.89 0.89-1.62 0.89-1.48 0.85-1.46 0.84-1.45 0.84-1.45

Comments : IF NOT ON DRUGS SUGGESTED FT3 & FT4 ESTIMATION

Please correlate with clinical conditions.
Note : Serum Tri-iodo-thyronine (T3), Thyroxine (T4) and Thyroid stimulating hormone (TSH) form the three components of thyroid
screening panel, useful in diagnosing various disorders of the thyroid gland. Primary Hypothyroidism is accompanied by depressed
serum T3 and T4 values and elevated serum TSH levels. Although elevated TSH levels are nearly always indicative of Primary
Hypothyroidism, rarely they can from TSH secreting pituitary tumors (Secondary hyperthyroidism)To confirm diagnosis - evaluate
FT3 and FT4.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 13 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:45
Sample Type Plain Serum, Serum Client Code

IRON PROFILE

Test Name Result Unit Normal Value

SERUM IRON 67.5 ugm/dl 59 - 158

UIBC 263.3 125 - 345
TOTAL IRON BINDING CAPACITY 330.8 ugm/dl 274 - 385
Percentage Transferrin Saturation 20.4 % 16.0 - 50.0
Limitations
Serum iron is not reliable as the primary test to identify iron deficiency or screening for Hemochromatosis and other iron overload
diseases. For these conditions, a serum TIBC, percent transferrin saturation, and ferritin assay are recommended. Diurnal variation
normal values in mid-morning, low values in mid-afternoon, very low values (~10 ug/dL) near mid- night. diurnal variation
disappears at levels <45 ug/dL. Iron dextran administration causes increase for several weeks ( may be >1000 ug/dL) Estrogenes
and oral contraceptives increased TIBC levels. Asparaginase,choramphenico,corticotropin,cortisone,and testosterone decrease the
TIBC levels. Fully Automated AU 480 Biochemistry Analyser
Use
Differential diagnosis of anemias
Should always be performed whenever serum iron is done to calculate percent saturation for diagnosis of iron defeciency
Screening for iron overload.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 14 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:46
Sample Type EDTA Blood, Serum Client Code

GLYCOSYLATED HEAMOGOLOBIN (GHB / HBA1c)

Test Name Result Unit Normal Value

HB A1c 5.4 % 0-6

6 -7 % Good Control
6.0% - 7.0% - Good Control
7.0% - 8.0% - Fair Contro
8.0% - 10% - Unsatisfactory
Control
Above 10% - Poor Control

HBA1C AVERAGE 108.28 90 - 120

90 - 120 mg/dl : Excellent Control
121 - 150 mg/dl : Good Control
151 - 180 mg/dl : Average Control
181 - 210 mg/dl : Action
Suggested
> 211 mg/dl : Panic Value
(Note: Average Blood Glucose
value is
calculated from HBA1c value and
it
indicates Average Blood Sugar
level over
past three months.)

REMARKS:-
In vitro quantitative determination of HbAIC in whole blood is utilized in long term monitoring of glycemia .
The HbAIC level correlates with the mean glucose concentration prevailing in the course of the patient's
recent history (approx - 6-8 weeks) and therefore provides much more reliable information for glycemia
monitoring than do determinations of blood glucose or urinary glucose.
It is recommended that the determination of HbAIC be performed at intervals of 4-6 weeksduring Diabetes
Mellitus therapy.

Page 15
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:46
Sample Type EDTA Blood, Serum Client Code

Results of HbAIC should be assessed in conjunction with the patient's medical history, clinical examinations
and other findings.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 16 CONSULTANT PATHOLOGIST
Barcode 2501220013 Test Request id 51901
Patient Name Mr. AKASH Reg. Date 22/01/2025 10:25:46
Age/Sex 34 Yrs.Male Reporting on 22/01/2025 18:39:24
Ref. By SELF Printing on 22/01/2025 18:39:47
Sample Type Client Code

IMPORTANT INSTRUCTIONS
 Test results released pertain to the specimen submitted .
 All test results are dependent on the quality of the sample received by the Laboratory .
 Laboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated
by the Referring Physician .
 Report delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .
 Certain tests may require further testing at additional cost for derivation of exact value. Kindly submit request
within 72 hours post reporting.
 Test results may show interlaboratory variations .
 The Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or
results of test(s).
 Test results are not valid for medico legal purposes.
 This is computer generated medical diagnostic report that has been validated by Authorized Medical
Practitioner /Doctor.
 The report does not need physical signature.

(#) Sample drawn from outside source.

If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for
possible remedial action.

**** End Of Report ****

Dr. NITIN KUMAR DUMEER

M.B.B.S., M.D Path
Page 17 of 17 CONSULTANT PATHOLOGIST